• About
  • Privacy Policy
  • Cookie Policy
  • Terms of Use 
  • My account
  • Contact
Tuesday, May 19, 2026
  • Login
Arab Health World
  • Home
    • About Us
    • Cookie Policy
    • Privacy Policy
    • Terms of Use 
  • Business Insights
    • Accreditation
    • Healthcare Regulation
    • Infrastructure
    • Insurance
    • Leadership
    • Medical Tourism
    • Mental health
    • Medical Investment and Finance
    • Healthcare Regulation
    • Nutrition and Healthcare Latest Trend
  • Tech
    • 3DPrinting
    • Artificial Intelligence
    • Automation
    • Blockchain
    • Big Data
    • Med Tech
    • Digital Health
    • Medical devices, equipment, and hospital supplies manufacturers
  • Clinical
    • Cardiology
    • Diabetes
    • Emergency Medicine
    • Obesitrics and Guneocology
    • Obesity
    • Oncology
    • Orthopedics
    • Otolaryngology
    • Padiatrics
    • Radiology
    • Surgery
  • Laboratories
    • Clinical Chemistry
    • Diagnostics
    • Gen Therapy
    • Immunology
    • IVF
    • Labratory Accrediation
    • Labratory Management
    • MicroBiology
  • Sectors
    • Optometry
    • Dental
    • Pharma
  • Magazine
  • Media Kit
No Result
View All Result
  • Home
    • About Us
    • Cookie Policy
    • Privacy Policy
    • Terms of Use 
  • Business Insights
    • Accreditation
    • Healthcare Regulation
    • Infrastructure
    • Insurance
    • Leadership
    • Medical Tourism
    • Mental health
    • Medical Investment and Finance
    • Healthcare Regulation
    • Nutrition and Healthcare Latest Trend
  • Tech
    • 3DPrinting
    • Artificial Intelligence
    • Automation
    • Blockchain
    • Big Data
    • Med Tech
    • Digital Health
    • Medical devices, equipment, and hospital supplies manufacturers
  • Clinical
    • Cardiology
    • Diabetes
    • Emergency Medicine
    • Obesitrics and Guneocology
    • Obesity
    • Oncology
    • Orthopedics
    • Otolaryngology
    • Padiatrics
    • Radiology
    • Surgery
  • Laboratories
    • Clinical Chemistry
    • Diagnostics
    • Gen Therapy
    • Immunology
    • IVF
    • Labratory Accrediation
    • Labratory Management
    • MicroBiology
  • Sectors
    • Optometry
    • Dental
    • Pharma
  • Magazine
  • Media Kit
No Result
View All Result
Arab Health World
No Result
View All Result
  • About Us
  • Cookie Policy
  • Privacy Policy
  • Terms of Use 
  • Contact
Home Business Insights

Cleveland Clinic Abu Dhabi reports 35% growth in international patient volume for 2024, boosting the UAE’s position in medical tourism

● Cleveland Clinic Abu Dhabi recorded over 10,000 international patients encounters in 2024, underscoring its position as a trusted destination for world class care ● The hospital’s continuous investment in cutting-edge technology, medical innovation, and pioneering research has earned it multiple regional and international accreditations

admin by admin
February 27, 2025
in Business Insights, Cardiology, Clinical, Clinical Chemistry, Digital Pathology, Healthcare Regulation, Laboratories, Leadership, Medical, Medical Investment and Finance, Medical Tourism, Mental health, Nutrition and Healthcare Latest Trend, Oncology, Orthopedics, Radiology, Sectors
0
0
Cleveland Clinic Abu Dhabi reports 35% growth in international patient volume for 2024, boosting the UAE’s position in medical tourism

TRIYAS_2023_ABUDAHABI

0
SHARES
133
VIEWS
Share on FacebookShare on Twitter

Abu Dhabi, United Arab Emirates. February 27, 2025: Cleveland Clinic Abu Dhabi, part of the M42 group, has recorded a 35% increase in international patient volume in 2024, cementing its position as a global destination for world-class care. Over the past twelve months, the hospital saw more than 10,000 international patients encounters, demonstrating its leadership in advanced and specialized care powered by cutting-edge technology and multidisciplinary expertise.

Renowned for its excellence in complex care, Cleveland Clinic Abu Dhabi saw increased interest in its advanced services, mainly in the aeras of cardiology, ophthalmology, neurology and urology, with Kuwait, Saudi Arabia, Pakistan, Bahrain and USA being the top five countries where international patients are flying from to Abu Dhabi in 2024.

As part of the Cleveland Clinic global network, the hospital ensures a seamless experience for its international patients through its representation in key regions worldwide. Its ongoing investment in advanced technology, medical innovation and research has earned it prestigious regional and international accreditations and certifications, underscoring its reputation as a premier healthcare destination. This growth highlights the hospital’s leadership in medical innovation and reinforces the UAE’s position as a premier hub for medical tourism.

Dr. Georges- Pascal Haber, CEO of Cleveland Clinic Abu Dhabi, stated: “At Cleveland Clinic Abu Dhabi, we are redefining healthcare in the UAE and beyond. Our vision is to become the premier destination for patients worldwide, delivering world-class, multidisciplinary care tailored to each individual’s needs—all within a single, state-of-the-art facility. What truly distinguishes us is not only our medical expertise but also our unwavering commitment to enhancing patient outcomes.

We are gaining global recognition and attracting patients who view the UAE as a hub for groundbreaking medical advancements. Our approach is setting a new standard for the future of healthcare—rooted in excellence, teamwork, and compassion. We are pushing the boundaries of possibility, ensuring that every patient, regardless of where they come from, departs with the confidence that they have received the best care available.”

Worth noting that in 2023, Cleveland Clinic Abu Dhabi recorded over 7,400 encounters for international patients, primarily from Kuwait, Saudi Arabia, Pakistan, Oman and Bahrain. Today, with its reputation for delivering high-quality medical services and complex care through its state-of-the-art institutes, including the Multi-Organ Transplant Center and the Fatima Bint Mubarak Oncology Center, Cleveland Clinic Abu Dhabi is attracting patients from around the globe.

Recalling her visit to the UAE, Esther Ritzmann, a Swiss national who survived a rare and life-threatening stroke, said: “I never expected that my vacation in the UAE would turn into a life-saving journey. I remember feeling my body completely paralyze. I felt trapped in my own body, unable to move, and the seizures hit me like waves. Somewhere in my subconscious, I thought I was going to die.”

 

Reflecting on her experience at Cleveland Clinic Abu Dhabi, Esther continued: “But when I arrived at Cleveland Clinic Abu Dhabi, everything changed. The team’s swift action, their expertise, and the way they communicated with me, even when I could barely respond, made me feel safe. I immediately trusted them with my life. Despite being thousands of miles away from home, I knew I was exactly where I needed to be. Their exceptional care saved my life, and I’ll forever be grateful for how they gave me the chance to recover and live again.”

Cleveland Clinic Abu Dhabi’s International Patient Services is designed to offer patients a seamless experience and provide access to world-class healthcare across a wide range of specialties. The program delivers personalized support throughout the entire patient journey, with a dedicated coordinator serving as a single point of contact. Services include scheduling appointments, travel assistance, managing medical records, cost estimation and payment support, hospital admission support and facilitating critical care transfers. The hospital plans to broaden its array of medical services by introducing specialized offerings that cater to the evolving needs of patients from around the world.

To know more about International Patient Services and book an appointment at Cleveland Clinic Abu Dhabi, call 800 8 CCAD (2223), visit https://www.clevelandclinicabudhabi.ae/en/international-patients/international-patient-services or download the Cleveland Clinic Abu Dhabi Patient Portal App.

About Cleveland Clinic Abu Dhabi

Cleveland Clinic Abu Dhabi, part of the M42 group, is a multispecialty hospital on Al Maryah Island in Abu Dhabi, UAE. Cleveland Clinic Abu Dhabi is a unique and unparalleled extension of US-based Cleveland Clinic’s model of care, specifically designed to address a range of complex and critical care requirements unique to the Abu Dhabi population. Cleveland Clinic Abu Dhabi has the following Institutes and Departments: Heart, Vascular & Thoracic, Neurology, Digestive Disease, Eye, Respiratory, Critical Care, Oncology, Transplant, Surgical Subspecialties, Medical Subspecialties, Emergency Medicine, Anesthesiology, Pathology & Laboratory Medicine, Imaging, Quality & Patient Safety, Clinical & Nursing, Research and Education Departments. In all, more than 50 medical and surgical specialties are offered at Cleveland Clinic Abu Dhabi.

The campus is also home to a stand-alone and dedicated cancer center, Fatima bint Mubarak Center. The state-of-the-art, facility provides patients with access to diagnostics and treatment options through world- class facilities across 24 clinical departments that include a range of cancer subspecialties and programs: Blood Cancers, Breast Cancers, Endocrine Cancers, Gastrointestinal Cancers, Genitourinary Cancers, Gynecological Cancers, Head and Neck Cancers, Neurological Cancers, Thoracic Cancers, Ophthalmological Cancers and Soft Tissue Cancers among others.

Cleveland Clinic Abu Dhabi provides patients in the region with direct access to the world’s best healthcare providers and Cleveland Clinic’s unique model of care that includes state-of-the-art amenities and world- class service standards closer to home. M42 is an Abu Dhabi-based, global tech-enabled healthcare company operating at the forefront of medical advancement.

Visit us at www.clevelandclinicabudhabi.ae

Source: Cleveland Clinic Abu Dhabi reports 35% growth in international patient volume for 2024, boosting the UAE's position in medical tourism
Via: Cleveland Clinic Abu Dhabi
Tags: #urologyAbu DhabiBahrainCARDIOLOGYCleveland ClinicCleveland Clinic Abu DhabiKuwaitM42 groupneurologyophthalmologyPakistanSaudi ArabiaUNITED ARAB EMIRATESUSA

Get real time update about this post categories directly on your device, subscribe now.

Unsubscribe
admin

admin

Related Posts

Regeneron misses again as melanoma combo bows to Merck’s Keytruda in Phase 3
Accreditation

Regeneron misses again as melanoma combo bows to Merck’s Keytruda in Phase 3

by admin
May 18, 2026
0

The late-stage miss shakes analyst confidence in Regeneron’s clinical execution, according to BMO Capital Markets, also noting last year’s Phase...

Read moreDetails

Workforce Shortage or Workforce Mismatch? Bridging the Generational Divide in a Post-Pandemic

Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

Rybelsus found to reduce major adverse cardiovascular events in Novo Nordisk trial

Sidra Medicine Publishes Impactful Study on Treatable Inherited Metabolic Disorders in Qatar

Stay Connected

  • 23.9k Followers
  • Trending
  • Comments
  • Latest
Cleveland Clinic Abu Dhabi reports 35% growth in international patient volume for 2024, boosting the UAE’s position in medical tourism

Cleveland Clinic Abu Dhabi reports 35% growth in international patient volume for 2024, boosting the UAE’s position in medical tourism

February 27, 2025

Sidra Medicine Publishes Impactful Study on Treatable Inherited Metabolic Disorders in Qatar

January 4, 2025
Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

April 7, 2025
Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

April 30, 2025

Sidra Medicine Publishes Impactful Study on Treatable Inherited Metabolic Disorders in Qatar

0
Cleveland Clinic Abu Dhabi reports 35% growth in international patient volume for 2024, boosting the UAE’s position in medical tourism

Cleveland Clinic Abu Dhabi reports 35% growth in international patient volume for 2024, boosting the UAE’s position in medical tourism

0
Rybelsus found to reduce major adverse cardiovascular events in Novo Nordisk trial

Rybelsus found to reduce major adverse cardiovascular events in Novo Nordisk trial

0
Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

0
Regeneron misses again as melanoma combo bows to Merck’s Keytruda in Phase 3

Regeneron misses again as melanoma combo bows to Merck’s Keytruda in Phase 3

May 18, 2026
Workforce Shortage or Workforce Mismatch? Bridging the Generational Divide in a Post-Pandemic

Workforce Shortage or Workforce Mismatch? Bridging the Generational Divide in a Post-Pandemic

December 27, 2025
Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

April 30, 2025
Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

April 7, 2025

Recent News

Regeneron misses again as melanoma combo bows to Merck’s Keytruda in Phase 3

Regeneron misses again as melanoma combo bows to Merck’s Keytruda in Phase 3

May 18, 2026
Workforce Shortage or Workforce Mismatch? Bridging the Generational Divide in a Post-Pandemic

Workforce Shortage or Workforce Mismatch? Bridging the Generational Divide in a Post-Pandemic

December 27, 2025
Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

April 30, 2025
Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

April 7, 2025

Arab Health World

This magazine is newsworthy, analytical, and informative, providing readers with unique and professional content as well as opinions and editorials that will focus on medical and healthcare development. This specialty magazine is also the choice of healthcare professionals and informed readers who need an informed monthly source of news and information in the regional healthcare industry. We aim for excellence in our scientific, health and commercial reports.

Recent News

Regeneron misses again as melanoma combo bows to Merck’s Keytruda in Phase 3

Regeneron misses again as melanoma combo bows to Merck’s Keytruda in Phase 3

May 18, 2026
Workforce Shortage or Workforce Mismatch? Bridging the Generational Divide in a Post-Pandemic

Workforce Shortage or Workforce Mismatch? Bridging the Generational Divide in a Post-Pandemic

December 27, 2025

Follow Us

  • About Us
  • Cookie Policy
  • Privacy Policy
  • Terms of Use 
  • Contact

© 2023 - ArabHealthWorld all rights reserved

Welcome Back!

Sign In with Facebook
Sign In with Google
Sign In with Linked In
OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Home
    • About Us
    • Cookie Policy
    • Privacy Policy
    • Terms of Use 
  • Business Insights
    • Accreditation
    • Healthcare Regulation
    • Infrastructure
    • Insurance
    • Leadership
    • Medical Tourism
    • Mental health
    • Medical Investment and Finance
    • Healthcare Regulation
    • Nutrition and Healthcare Latest Trend
  • Tech
    • 3DPrinting
    • Artificial Intelligence
    • Automation
    • Blockchain
    • Big Data
    • Med Tech
    • Digital Health
    • Medical devices, equipment, and hospital supplies manufacturers
  • Clinical
    • Cardiology
    • Diabetes
    • Emergency Medicine
    • Obesitrics and Guneocology
    • Obesity
    • Oncology
    • Orthopedics
    • Otolaryngology
    • Padiatrics
    • Radiology
    • Surgery
  • Laboratories
    • Clinical Chemistry
    • Diagnostics
    • Gen Therapy
    • Immunology
    • IVF
    • Labratory Accrediation
    • Labratory Management
    • MicroBiology
  • Sectors
    • Optometry
    • Dental
    • Pharma
  • Magazine
  • Media Kit

© 2023 - ArabHealthWorld all rights reserved